MedTrace Logo

Multidisciplinary Study of Right Ventricular Dysplasia

NCT00024505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2013-01-17

No results posted yet for this study

Summary

The purpose of this study is to investigate the cardiac, clinical, and genetic aspects of arrhythmogenic right ventricular dysplasia (ARVD), a progressive disorder that predominantly affects the right side of the heart and causes ventricular arrhythmias.

Conditions

  • Heart Diseases
  • Arrhythmogenic Right Ventricular Dysplasia

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Arizona

    lead OTHER

Principal Investigators

  • Frank I. Marcus, MD · University of Arizona

  • Jeffrey Towbin · Baylor College of Medicine

  • Wojciech Zareba · University of Rochester

Eligibility

Min Age
12 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00024505 on ClinicalTrials.gov